Subsidiary of Fuan Pharmaceutical (300194.SZ) obtains a drug registration certificate.
Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary, Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical Co., Ltd. (referred to as "Tianheng Pharmaceutical"), recently received a drug registration certificate issued by the National Medical Products Administration. The drug is called Metronidazole Sodium Chloride Injection.
Announcement from Fuan Pharmaceutical (300194.SZ): The company's wholly-owned subsidiary, Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical Co., Ltd. (referred to as "Tianheng Pharmaceuticals"), recently received a drug registration certificate issued by the National Medical Products Administration. The drug name is Metronidazole Sodium Chloride Injection.
Related Articles
BINHAI INV (02886) spent HKD 120,700 on April 13 to repurchase 106,000 shares.
Chairman Wang Linbing of HARBOURHOLD (01663) acquired 5.7 million shares.
TRULY INT'L (00732) spent HK$481,100 to repurchase 486,000 shares on April 13th.
BINHAI INV (02886) spent HKD 120,700 on April 13 to repurchase 106,000 shares.
Chairman Wang Linbing of HARBOURHOLD (01663) acquired 5.7 million shares.
TRULY INT'L (00732) spent HK$481,100 to repurchase 486,000 shares on April 13th.
RECOMMEND
